JNJ dividend yield: 3.36%. LRCX dividend yield: 4.00%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. LRCX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in LRCX shares.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
LRCX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in LRCX shares.
Is JNJ or LRCX better for dividend income in 2026?
JNJ currently offers a 3.36% yield (4.96/share/year) while LRCX offers 4.00% (2.00/share/year). LRCX provides higher current income. However, JNJ has grown its dividend faster (5.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs LRCX earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. LRCX pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $899/year (LRCX).
Does JNJ or LRCX pay monthly dividends?
JNJ pays quarterly dividends. LRCX pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs LRCX comparison by email
Save your analysis + get weekly dividend insights. Free forever.